The relatively low sensitivity in the detection of high-grade lesions, even when combining conventional cytology and NGS, is largely the result of the fact that pathogenic variants of TP53/CDKN2A/SMAD4 are often not detected in pancreatic cyst fluids, even in those of histopathologically confirmed high-grade lesions. The gene discussed is TP53; the disease is Pancreatic cysts.